Naloxegol Oxalate | Interleukin Related interleukin-related.com

Product Name :
Naloxegol Oxalate

Search keywords :
Naloxegol

drugId :
null

Target Vo:
Mu opioid receptor

Target Vo Short Name :
MOR1

Moa_Name:
Mu opioid receptor antagonists

First Approval Country :
United States

First Approval Date Filter:
2014

Origin Company_Name :
Astrazeneca Plc

Active Company_Name :
Daiichi Sankyo Co Ltd

Active Indication_Name:
Opioid-Related Disorders

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PKC alpha Antibody
CLDN1 Antibody
CD73 Antibody (YA528): CD73 Antibody (YA528) is a non-conjugated and Rabbit origined monoclonal antibody about 63 kDa, targeting to CD73. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts